Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB26FDD70
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,927
Award facts
- Contract value 100% obligated
- $13,926.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for XOLAIR 150 mg/ml syringe on October 20, 2025. This firm fixed-price delivery order, valued at $13,926.60, carries an ultimate completion date of November 10, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award supports the Department of Defense's pharmaceutical supply chain needs, with performance taking place at the vendor's Park Ridge facility.
This delivery order falls under DMS Pharmaceutical Group's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract with the Defense Logistics Agency, a $30.3 billion governmentwide acquisition strategy designed to support recurring medical supply needs across military healthcare facilities worldwide. The prime vendor indefinite delivery contract, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group's demonstrated performance across multiple therapeutic categories positions the contractor as a critical supplier within the federal military medical system with no identified subcontractors.
Quick answers
Who was awarded contract SPE2DB26FDD70?
SPE2DB26FDD70 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FDD70 worth?
The government has obligated $13,927 on SPE2DB26FDD70.
Is contract SPE2DB26FDD70 an order under another contract?
Yes. SPE2DB26FDD70 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB26FDD70 competed?
The extent of competition for SPE2DB26FDD70 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award